Takeda Pharmaceutical Co Ltd (TAK)
13.08
-0.09
(-0.68%)
USD |
NYSE |
Apr 30, 16:00
13.08
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Price to Book Value: 0.8585 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 0.8585 |
| April 29, 2024 | 0.8644 |
| April 26, 2024 | 0.8552 |
| April 25, 2024 | 0.8579 |
| April 24, 2024 | 0.8684 |
| April 23, 2024 | 0.8782 |
| April 22, 2024 | 0.8769 |
| April 19, 2024 | 0.869 |
| April 18, 2024 | 0.8638 |
| April 17, 2024 | 0.8631 |
| April 16, 2024 | 0.8684 |
| April 15, 2024 | 0.8651 |
| April 12, 2024 | 0.8775 |
| April 11, 2024 | 0.8913 |
| April 10, 2024 | 0.8907 |
| April 09, 2024 | 0.8959 |
| April 08, 2024 | 0.8972 |
| April 05, 2024 | 0.894 |
| April 04, 2024 | 0.8848 |
| April 03, 2024 | 0.888 |
| April 02, 2024 | 0.8894 |
| April 01, 2024 | 0.8972 |
| March 28, 2024 | 0.9117 |
| March 27, 2024 | 0.9314 |
| March 26, 2024 | 0.9445 |
| Date | Value |
|---|---|
| March 25, 2024 | 0.9287 |
| March 22, 2024 | 0.9458 |
| March 21, 2024 | 0.9425 |
| March 20, 2024 | 0.955 |
| March 19, 2024 | 0.9458 |
| March 18, 2024 | 0.9556 |
| March 15, 2024 | 0.9497 |
| March 14, 2024 | 0.9412 |
| March 13, 2024 | 0.9465 |
| March 12, 2024 | 0.9432 |
| March 11, 2024 | 0.9563 |
| March 08, 2024 | 0.9694 |
| March 07, 2024 | 0.9753 |
| March 06, 2024 | 0.9642 |
| March 05, 2024 | 0.9451 |
| March 04, 2024 | 0.9504 |
| March 01, 2024 | 0.9556 |
| February 29, 2024 | 0.9576 |
| February 28, 2024 | 0.9616 |
| February 27, 2024 | 0.974 |
| February 26, 2024 | 0.9721 |
| February 23, 2024 | 0.9596 |
| February 22, 2024 | 0.9609 |
| February 21, 2024 | 0.9675 |
| February 20, 2024 | 0.9727 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.831
Minimum
Oct 19 2022
1.457
Maximum
Nov 19 2019
1.098
Average
1.082
Median
Aug 06 2021
Price to Book Value Benchmarks
| Hoya Corp | 6.515 |
| Astellas Pharma Inc | 1.606 |
| Nxera Pharma Co Ltd | 1.757 |
| PeptiDream Inc | 5.939 |
| Stemcell Holdings Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 32.58 |
| PS Ratio | 1.388 |
| Price | 13.08 |
| Earnings Yield | 3.07% |
| Market Cap | 41.04B |
| Operating PE Ratio | 16.62 |
| Normalized PE Ratio | 32.58 |